Overview

A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and safety of the sublingual Sufentanil Tablet (ST) 30 mcg to the sublingual Placebo Tablet (PT) for the short-term management of moderate-to-severe acute post-operative pain in patients after abdominal surgery.

Phase:

Phase 3

Details

Lead Sponsor:

AcelRx Pharmaceuticals, Inc.

Treatments:

Sufentanil